Entity Detail — Knowledge Graph Node
This page aggregates everything SciDEX knows about metformin: its mechanistic relationships (Knowledge Graph edges), hypotheses targeting it, analyses mentioning it, and supporting scientific papers. The interactive graph below shows its immediate neighbors. All content is AI-synthesized from peer-reviewed literature.
No summary available yet. View on Wiki →
| Gene Symbol | metformin |
| NCT Number | NCT07055958 |
| Title | Metformin Add-on Therapy for Parkinson's Disease |
| Status | Recruiting |
| Phase | Phase II |
| Condition(s) | Parkinson's Disease |
| Intervention | Metformin hydrochloride 500mg twice daily + standard Levodopa/Carbidopa |
| Sponsor | Bangabandhu Sheikh Mujib Medical University, Bangladesh |
| Location | Dhaka, Bangladesh |
| Enrollment | 60 patients (estimated) |
| Study Duration | 52 weeks |
| Known Drugs/Compounds | AMPK, Parkinson's disease, Alzheimer's disease, type 2 diabetes mellitus, reactive oxygen species production, epilepsy |
| KG Connections | 95 knowledge graph edges |
| Databases | GeneCardsUniProtNCBI GeneHPASTRING |
Knowledge base pages for this entity
graph TD
metformin["metformin"] -.->|"inhibits"| astrocyte_senescence["astrocyte senescence"]
style astrocyte_senescence fill:#1a2a3a,stroke:#ffd54f,stroke-width:1px,color:#fff
metformin["metformin"] -->|"treats"| insulin_sensitivity["insulin sensitivity"]
style insulin_sensitivity fill:#1a2a3a,stroke:#ffd54f,stroke-width:1px,color:#fff
metformin["metformin"] -->|"regulates"| mitochondrial_function["mitochondrial function"]
style mitochondrial_function fill:#1a2a3a,stroke:#ffd54f,stroke-width:1px,color:#fff
metformin["metformin"] -->|"treats"| diabetes["diabetes"]
style diabetes fill:#1a2a3a,stroke:#ef5350,stroke-width:1px,color:#fff
metformin["metformin"] -.->|"suppresses"| MCOLN1["MCOLN1"]
style MCOLN1 fill:#1a2a3a,stroke:#ce93d8,stroke-width:1px,color:#fff
metformin["metformin"] -->|"prevents"| dopamine_neuron_injury["dopamine neuron injury"]
style dopamine_neuron_injury fill:#1a2a3a,stroke:#ffd54f,stroke-width:1px,color:#fff
metformin["metformin"] -->|"activates"| PRKAA2["PRKAA2"]
style PRKAA2 fill:#1a2a3a,stroke:#ce93d8,stroke-width:1px,color:#fff
style metformin fill:#006494,stroke:#4fc3f7,stroke-width:2px,color:#e0e0e0,font-weight:bold| Target | Relation | Type | Str |
|---|---|---|---|
| astrocyte senescence | inhibits | process | 0.95 |
| insulin sensitivity | treats | phenotype | 0.90 |
| mitochondrial function | regulates | process | 0.90 |
| MCOLN1 | suppresses | gene | 0.90 |
| dopamine neuron injury | prevents | phenotype | 0.88 |
| PRKAA2 | activates | gene | 0.85 |
| Drug-Induced Lung Injury | treats | disease | 0.85 |
| autophagosome-lysosome fusion | associated_with | process | 0.85 |
| AMPK | activates | protein | 0.80 |
| AMPK | targets | gene | 0.80 |
| BMAL1 | regulates | gene | 0.70 |
| Parkinson's disease | treats | disease | 0.70 |
| Alzheimer's disease | treats | disease | 0.70 |
| type 2 diabetes mellitus | treats | disease | 0.70 |
| reactive oxygen species production | inhibits | process | 0.70 |
| epilepsy | treats | disease | 0.70 |
| SIRT1 | targets | gene | 0.70 |
| PRKAA1 | targets | gene | 0.70 |
| PPARGC1A | targets | gene | 0.70 |
| NAD+ metabolism | modulates | pathway | 0.65 |
| Alzheimer's disease | therapeutic_target | disease | 0.60 |
| DNM1L | targets | gene | 0.60 |
| ATP | targets | gene | 0.60 |
| GLI1 | targets | gene | 0.60 |
| METTL3 | targets | gene | 0.60 |
| GFAP | targets | gene | 0.60 |
| PI3K | targets | gene | 0.60 |
| PKC | targets | gene | 0.60 |
| AND | targets | gene | 0.60 |
| DNA | targets | gene | 0.60 |
| TREM2 | targets | gene | 0.60 |
| SYK | targets | gene | 0.60 |
| TNC | targets | gene | 0.60 |
| NLRP3 | targets | gene | 0.60 |
| BDNF | targets | gene | 0.60 |
| STING | targets | gene | 0.60 |
| LKB1 | targets | gene | 0.60 |
| CNTF | targets | gene | 0.60 |
| MOG | targets | gene | 0.60 |
| MBP | targets | gene | 0.60 |
| NGF | targets | gene | 0.60 |
| multiple sclerosis | treats | disease | 0.60 |
| TLR | targets | gene | 0.60 |
| MAPK | targets | gene | 0.60 |
| TNF | targets | gene | 0.60 |
| EGR1 | targets | gene | 0.60 |
| ERK | targets | gene | 0.60 |
| CDK5 | targets | gene | 0.60 |
| HG | targets | gene | 0.60 |
| GLI | targets | gene | 0.60 |
| Source | Relation | Type | Str |
|---|---|---|---|
| PRKAA1 | therapeutic_target | gene | 0.90 |
| PRKAA2 | therapeutic_target | gene | 0.90 |
| AMPK | treats | gene | 0.65 |
| ENDOTHELIAL | causes | cell_type | 0.65 |
| DIABETES | contributes_to | disease | 0.65 |
| CA1 | protects_against | brain_region | 0.65 |
| GFAP | protects_against | gene | 0.65 |
| ALZHEIMER | treats | disease | 0.65 |
| ALZHEIMER'S DISEASE | treats | disease | 0.65 |
| DIABETES | treats | disease | 0.65 |
| BDNF | promotes | gene | 0.65 |
| CGAS | mediates | gene | 0.65 |
| SYK | regulates | gene | 0.65 |
| HEPATOCYTES | treats | cell_type | 0.65 |
| DIABETES | targets | disease | 0.65 |
| TREM2 | protects_against | gene | 0.65 |
| TH | causes | gene | 0.65 |
| NICOTINAMIDE | activates | drug | 0.65 |
| NICOTINAMIDE | treats | drug | 0.65 |
| MLKL | inhibits | gene | 0.65 |
| MLKL | activates | gene | 0.65 |
| NEURONS | treats | cell_type | 0.65 |
| CYTOKINES | inhibits | phenotype | 0.65 |
| TNF | inhibits | gene | 0.65 |
| OXIDATIVE STRESS | regulates | phenotype | 0.65 |
| COGNITIVE DECLINE | activates | phenotype | 0.65 |
| AMYLOID PLAQUES | protects_against | phenotype | 0.65 |
| PARKINSON'S DISEASE | targets | disease | 0.65 |
| AKT | regulates | gene | 0.65 |
| CCL2 | inhibits | gene | 0.65 |
| AMPK | implicated_in | gene | 0.55 |
| AMPK | participates_in | gene | 0.55 |
| PARKINSON'S DISEASE | participates_in | disease | 0.55 |
| AUTOPHAGY | activates | process | 0.50 |
| AMPK | upregulates | gene | 0.50 |
| SIRT1 | upregulates | gene | 0.50 |
| INFLAMMATION | associated_with | process | 0.50 |
| T CELL | inhibits | cell_type | 0.50 |
| AGING | protects_against | process | 0.50 |
| AGING | inhibits | process | 0.50 |
| TREM2 | inhibits | gene | 0.50 |
| NEUROINFLAMMATION | inhibits | process | 0.50 |
| TREM2 | regulates | gene | 0.50 |
| NEUROINFLAMMATION | regulates | process | 0.50 |
| NLRP3 | activates | gene | 0.50 |
| MICROGLIA | activates | cell_type | 0.50 |
| TREM2 | activates | gene | 0.50 |
| AMPK | activates | gene | 0.50 |
| SIRT1 | activates | gene | 0.50 |
| SIRT1 | associated_with | gene | 0.50 |
Hypotheses where this entity is a therapeutic target
| Hypothesis | Score | Disease | Analysis |
|---|---|---|---|
| No targeting hypotheses | |||
Scientific analyses that reference this entity
neurodegeneration | 2026-04-14 | 0 hypotheses
neurodegeneration | 2026-04-02 | 3 hypotheses Top: 0.398
Scientific publications cited in analyses involving this entity
| Title & PMID | Authors | Journal | Year | Citations |
|---|---|---|---|---|
| No papers found | ||||